Hypothalamic
Kisspeptin GnRH Protocol
The KISS1 gene product and master upstream regulator of the HPG axis — investigated in research models for GnRH neuronal activation, LH/FSH pulsatility, puberty-onset signalling and hypothalamic amenorrhoea endpoints.
KISS1R Mechanism
How a single hypothalamic peptide sits at the apex of mammalian reproductive neuroendocrinology.
Receptor Binding
Encoded by the KISS1 gene, kisspeptin binds GPR54 (KISS1R) on hypothalamic GnRH neurons, acting as a primary upstream gate for the entire reproductive axis in research models.
HPG-Axis Activation
Studied for its capacity to trigger pulsatile GnRH release, in turn driving downstream LH and FSH secretion from the anterior pituitary in reproductive neuroendocrinology experiments.
Developmental Signalling
Investigated as the gating signal for puberty onset and as a research tool in hypothalamic amenorrhoea, fertility neuroendocrinology and functional hypogonadism preclinical models.
Research Applications
Three principal domains where kisspeptin functions as a reference probe in reproductive research.
Master Regulator
Used to interrogate upstream control of the hypothalamic-pituitary-gonadal axis, including KISS1R agonism, GnRH pulse generation and integration of metabolic and steroidal feedback.
Fertility Models
Investigated in research models of hypothalamic amenorrhoea, functional hypogonadism and assisted-reproduction physiology, providing a clean upstream stimulus for ovulatory and spermatogenic axes.
Pulse-Generator Research
Featured in studies of the arcuate KNDy network and GnRH pulse-generator dynamics, with LH pulsatility serving as the standard readout for kisspeptin-evoked neuroendocrine output.
Compound Profile
Identity at a glance.
| Property | Detail |
|---|---|
| Sequence (kisspeptin-10) | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 |
| Formula & weight | C63H83N17O14 · 1302.4 g/mol · CAS 374675-21-5 |
| Family | Kisspeptins 54, 14, 13 and 10 are cleaved from the KISS1 precursor and share the same C-terminal decapeptide, which carries receptor activity |
| Receptor | KISS1R (formerly GPR54), a Gq-coupled receptor on GnRH neurons |
| Regulatory status | No approved kisspeptin medicine; used in academic clinical research, particularly in the UK |
Published Research
The studies that established kisspeptin’s role in reproduction.
| Study | What it found |
|---|---|
| 2003 — GPR54 and puberty | Two groups independently found that loss-of-function mutations in GPR54 cause hypogonadotropic hypogonadism, identifying kisspeptin signalling as essential for puberty and fertility.1,2 |
| 2014 — IVF egg maturation | A single dose of kisspeptin-54 triggered egg maturation in women undergoing IVF, resulting in successful pregnancies.3 |
| 2015 — OHSS-risk patients | In women at high risk of ovarian hyperstimulation syndrome, kisspeptin-54 triggered oocyte maturation with low rates of OHSS in a phase 2 trial.4 |
| 2022 — Women with low desire | In a randomised crossover trial in premenopausal women with hypoactive sexual desire disorder, kisspeptin modulated sexual and attraction brain processing on functional MRI.5 |
| 2023 — Men with low desire | In men with hypoactive sexual desire disorder, kisspeptin increased brain activity in sexual-processing networks and penile tumescence in response to erotic stimuli compared with placebo.6 |
Evidence Quality & Limitations
Kisspeptin’s role in human reproduction is among the best-validated of any peptide in these guides, supported by human genetics and randomised clinical studies. Most clinical work has been done by a small number of academic centres, trials have been short and relatively small, and no kisspeptin product has been approved. Kisspeptin-10 and kisspeptin-54 differ markedly in half-life, so findings with one form do not transfer directly to the other.
References
- Seminara SB, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349:1614–27. PubMed
- de Roux N, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA. 2003;100:10972–6. PubMed
- Jayasena CN, et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest. 2014;124:3667–77. PubMed
- Abbara A, et al. Efficacy of kisspeptin-54 to trigger oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy. J Clin Endocrinol Metab. 2015;100:3322–31. PubMed
- Thurston L, et al. Effects of kisspeptin administration in women with hypoactive sexual desire disorder: a randomized clinical trial. JAMA Netw Open. 2022;5:e2236131. PubMed
- Mills EG, et al. Effects of kisspeptin on sexual brain processing and penile tumescence in men with hypoactive sexual desire disorder: a randomized clinical trial. JAMA Netw Open. 2023;6:e2254313. PubMed
Technical FAQ
Questions researchers ask most often.
How does kisspeptin compare to exogenous GnRH in research?
GnRH acts directly at the pituitary, bypassing hypothalamic control. Kisspeptin acts one step upstream at the GnRH neuron itself via KISS1R, allowing investigators to study endogenous pulse-generator behaviour and feedback integration rather than overriding it — a more physiological probe in many neuroendocrine models.
What is the stability and storage profile?
Kisspeptin is lyophilised for maximum molecular stability. Store the dry vial in a cool, dark environment. Following reconstitution with Bacteriostatic Water, refrigerate and use within the validated stability window for the protocol.
What dosing protocol is used in research?
Preclinical protocols typically employ pulsatile or bolus administration in rodent and large-animal HPG-axis models, with LH and FSH sampling used as the primary readout. Strictly for laboratory research use only — not for human consumption.
